Novavax Aktie
8,29
EUR
-0,12
EUR
-1,45
%
8,43
USD
+0,03
USD
+0,36
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 5 | 4 | 0 | 138,37 GBP | +26,50% |
| Bayer | 1 | 8 | 0 | 24,12 EUR | +14,20% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,50 USD | +21,95% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 2 | 5 | 3 | 40,03 EUR | -10,93% |
| Fresenius SE & Co. KGaA (St.) | 8 | 1 | 0 | 40,86 EUR | +12,53% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +97,68% |
| Novartis AG | 3 | 5 | 1 | 98,86 CHF | +10,68% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 31,20 USD | +18,63% |
| Roche AG (Genussschein) | 2 | 4 | 3 | 274,86 CHF | +3,56% |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +11,69% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |